snc logo
AI Search Beta
Search Limit Reached
To ensure smooth performance and fair access for all users, AI searches are limited within a set timeframe. Please try again later.
Companies
Add Entity
snc-logo

Startup Nation Finder

My Watchlists
Ecosystem
Startups
Investors
Hubs
Multinationals
Reports toggle reports submenu
Saved Searches
Following
Messaging
Notifications
About Us
Glossary

Create Watchlist

Watchlist name*
Watchlist must have a valid name.
Description (optional)
0/300
Notifications Settings
Public content (accessible by all Finder users)

Add to List

    Notifications settings

    Set Notifications
    Off
    Select notifications to recieve tooltip-info
    Select all

    Email Alerts

    Receive notifications via email

    No Notifications are selected

    Would you like to select any notifications?
    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    The invitation to claim the profile was originally sent to

    or  

    Hey #USER_FULLNAME#!
    Claim #COMPANY_NAME#’s profile to become an administrator with editing privileges in
    #COMPANY_NAME#’s page on Startup Nation Finder

    Suggest Edits

    Let us know what you think is inaccurate or missing.
    We will check it out and update the profile if needed.

    Claim Profile

    Please provide us the following information. Note that you need to have an email in this organization in order to claim the profile.

    Create Free Account
    Lock Icon
    Lock Icon
    8 Characters, Uppercase letter (A-Z),
    Lowercase letter (a-z), Digit (0-9)
    Lock Icon
    Passwords do not match
    Already have an account? Sign In
    Or continue with

    Verify your email

    We’ve sent a verification link to [email protected]
    Sign in
    Lock Icon
    Lock Icon
    Reset password
    Don't have an account? Create Account
    Or continue with

    Check your mailbox

    We sent you an email with further instructions to
    [email protected]

    Do not forget to check your spam folder

    Didn’t get the email? Resend email or Contact us

    Password must contain at least 8 characters, one digit, one uppercase and one lowercase letter.

    Save Search

    Search must have a valid name.

    Rename Search

    Search must have a valid name.
    Delete Saved Search Confirmation
    search will be permanently removed from Finder.
    News Analysis
    snackbar-icon
    title
    message
    Search Startups

    Stage C and Stage Acquired, Drugs Discovery & Development Startups

    Processing your search... This may take a moment
    43 Startups 0 In the News 1 Recently Updated
    • Total Funding
      $3.42B
      Raised
      101
      Events
    • Private Funding
      $787.37M
      Raised
      50
      Rounds
    • Public Offerings
      $531.71M
      Raised
      20
      Offerings
    • M&A
      $2.1B
      Raised
      31
      Deals
    Funding
    Number of Employees
    Rounds / Deals
    Funding Stage
    Tags
    KAHR Medical logo

    KAHR Medical

    Fusion Proteins for Treating Cancer and Autoimmune Diseases
    2005 B2B 11-50 C $100M
    cancer
    biological-therapy
    drug-delivery
    drug-discovery
    pharmaceuticals
    autoimmune-diseases
    chronic-patients
    biopharmaceutical
    pharma-companies
    Omnix Medical logo

    Omnix Medical

    Novel Antibiotic Agents to Combat Resistant Bacteria
    2015 B2B 11-50 C $25.44M
    drug-discovery
    patients
    pharmaceuticals
    infection
    bacteria
    hospitals
    doctors
    Anchiano Therapeutics logo

    Anchiano Therapeutics

    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    2004 B2B 1-10 Acquired $37.7M
    cancer
    biotechnology
    biopharmaceutical
    cell-therapy
    biopsy
    targeted-therapy
    pharma-companies
    Applied Immune Technologies logo

    Applied Immune Technologies

    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    2006 B2B 1-10 Acquired $4.4M
    viral-diseases
    cancer
    antibodies
    biotechnology
    biopharmaceutical
    therapeutics
    diagnostics
    autoimmune-diseases
    patients
    doctors
    Ayala Pharmaceuticals logo

    Ayala Pharmaceuticals

    Acquired
    Targeted Therapies for People with Rare Cancers
    2017 B2B 11-50 Acquired $102M
    rare-diseases
    cancer
    genomics
    cell-therapy
    drug-discovery
    oncology
    therapeutics
    pharmaceuticals
    life-sciences
    patients
    Azura Ophthalmics logo

    Azura Ophthalmics

    Ophthalmic Keratolytics
    2013 B2B 11-50 C $37.2M
    medication
    drug-discovery
    ophthalmology
    chronic-patients
    biotechnology
    eye-diseases
    Biond Biologics logo

    Biond Biologics

    Immunotherapies for Cancer and Auto-immune Diseases
    2016 B2B 11-50 C $37M
    pharmaceuticals
    immunology
    drug-discovery
    oncology
    autoimmune-diseases
    biopharmaceutical
    cancer
    pharma-companies
    immunotherapy
    Processing your search... This may take a moment
    Startup AI Search Beta
    Search notes

    Search Startups

    43 Results
    Funding Amount
    Funding Stages
    • Total Funding
      $3.42B
      Raised
      101
      Events
    • Private Funding
      $787.37M
      Raised
      50
      Rounds
    • Public Offerings
      $531.71M
      Raised
      20
      Offerings
    • M&A
      $2.1B
      Raised
      31
      Deals

    Funding

    Rounds / Deals

    Funding Stage

    Number of Employees

    KAHR Medical logo
    Raised
    $100M
    KAHR Medical
    Fusion Proteins for Treating Cancer and Autoimmune Diseases
    Founded:2005
    Business Model:B2B
    Employees:11-50
    Funding Stage:C
    Omnix Medical logo
    Raised
    $25.44M
    Omnix Medical
    Novel Antibiotic Agents to Combat Resistant Bacteria
    Founded:2015
    Business Model:B2B
    Employees:11-50
    Funding Stage:C
    Anchiano Therapeutics logo
    Raised
    $37.7M
    Anchiano Therapeutics
    PRESUMED INACTIVE
    Targeted Cancer Therapies Based on H19 Gene
    Founded:2004
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Applied Immune Technologies logo
    Raised
    $4.4M
    Applied Immune Technologies
    PRESUMED INACTIVE
    TCRL Antibodies for Therapeutic Applications
    Founded:2006
    Business Model:B2B
    Employees:1-10
    Funding Stage:Acquired
    Ayala Pharmaceuticals logo
    Raised
    $102M
    Ayala Pharmaceuticals
    Acquired
    Targeted Therapies for People with Rare Cancers
    Founded:2017
    Business Model:B2B
    Employees:11-50
    Funding Stage:Acquired
    Azura Ophthalmics logo
    Raised
    $37.2M
    Azura Ophthalmics
    Ophthalmic Keratolytics
    Founded:2013
    Business Model:B2B
    Employees:11-50
    Funding Stage:C
    Biond Biologics logo
    Raised
    $37M
    Biond Biologics
    Immunotherapies for Cancer and Auto-immune Diseases
    Founded:2016
    Business Model:B2B
    Employees:11-50
    Funding Stage:C
    Access Comprehensive Financial Analytics
    Create a free account to:
    • Explore detailed financial analytics.
    • Track company growth and size.
    • Connect with company team members.
    I already have access,
    I already have access,